Molecular basis of in vivo resistance to sulfadoxine-pyrimethamine in African adult patients infected with Plasmodium falciparum malaria parasites

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 7, 1998, Pages 1811-1814

  Basco, Leonardo K ^a,b,c,d   Tahar, Rachida ^c   Ringwald, Pascal ^a,b  

^a Inst Francais Rech Sci pour le D   (Cameroon)

^b Laboratoire de Recherche sur le Paludisme Yaounde   (Cameroon)

^c CNRS   (France)

^d Institut de Recherche pour le Developpement Cameroon   (Cameroon)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROFOLATE REDUCTASE; DIHYDROPTEROATE SYNTHASE; FANSIDAR;

ADOLESCENT; ADULT; ARTICLE; CAMEROON; CLINICAL ARTICLE; DNA SEQUENCE; FEMALE; FOLLOW UP; GENOTYPE; HUMAN; MALARIA FALCIPARUM; MALE; PHENOTYPE; PLASMODIUM FALCIPARUM; POINT MUTATION; PRIORITY JOURNAL;

EID: 0031807606     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.7.1811     Document Type: Article

References (35)

1. Basco, L. K., P. Eldin de Pécoulas, J. Le Bras, and C. M. Wilson. 1996. Plasmodium falciparum: molecular characterization of multidrug-resistant Cambodian isolates. Exp. Parasitol. 82:97-103.
2. Basco, L. K., P. Eldin de Pécoulas, C. M. Wilson, J. Le Bras, and A. Mazabraud. 1995. Point mutations in the dihydrofolate reductase-thymidylate synthase gene and pyrimethamine and cycloguanil resistance in Plasmodium falciparum. Mol. Biochem. Parasitol. 69:135-138.
3. Basco, L. K., J. Le Bras, Z. Rhoades, and C. M. Wilson. 1995. Analysis of pfmdr 1 and drug susceptibility in fresh isolates of Plasmodium falciparum from Subsaharan Africa. Mol. Biochem. Parasitol. 74:157-166.
4. Basco, L. K., O. Ramiliarisoa, and J. Le Bras. 1994. In vitro activity of pyrimethamine, cycloguanil, and other antimalarial drugs against African isolates and clones of Plasmodium falciparum. Am. J. Trop. Med. Hyg. 50: 193-199.
5. Basco, L. K., and P. Ringwald. 1998. Molecular epidemiology of malaria in Yaoundé, Cameroon. II. Baseline frequency of point mutations in the dihydropteroate synthase gene of Plasmodium falciparum. Am. J. Trop. Med. Hyg. 58:374-378.
6. Brooks, D. R., P. Wang, M. Read, W. M. Watkins, P. F. G. Sims, and J. E. Hyde. 1994. Sequence variation of the hydroxymethyldihydropterin pyrophosphokinase:dihydropteroate synthase gene in lines of the human malaria parasite. Plasmodium falciparum, with differing resistance to sulfadoxine. Eur. J. Biochem. 2:397-405.
7. Chulay, J. D., W. M. Watkins, and D. G. Sixsmith. 1984. Synergistic anti-malarial activity of pyrimethamine and sulfadoxine against Plasmodium falciparum in vitro. Am. J. Trop. Med. Hyg. 33:325-330.
8. Eldin de Pécoulas, P., L. K. Basco, B. Abdallah, M. K. Djé, J. Le Bras, and A. Mazabraud. 1995. Plasmodium falciparum: detection of antifolate resistance by mutation-specific restriction enzyme digestion. Exp. Parasitol. 80: 483-487.
9. Foote, S. J., D. Galatas, and A. F. Cowman. 1990. Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance. Proc. Natl. Acad. Sci. USA 87:3014-3017.
10. Hyde, J. E. 1990. The dihydrofolate reductase-thymidylate synthetase gene in the drug resistance of malaria parasites. Pharmacol. Ther. 48:45-59.
11. Khan, B., S. Omar, J. N. Kanyara, M. Warren-Perry, J. Nyalwidhe, D. S. Peterson, T. Wellems, S. Kaniaru, J. Gitonga, F. J. Mulaa, and D. K. Koech. 1997. Antifolate drug resistance and point mutations in Plasmodium falciparum in Kenya. Trans. R. Soc. Trop. Med. Hyg. 91:456-460.
12. Müller, O., M. Boele van Hensbroek, S. Jaffar, C. Drakeley, D. Joof, M. Pinder, and B. Greenwood. 1996. A randomized trial of chloroquine, amodiaquine and pyrimethamine-sulphadoxine in Gambian children with uncomplicated malaria. Trop. Med. Int. Health 1:124-132.
13. Nzila-Mounda, A., E. K. Mberu, C. H. Sibley, C. V. Plowe, P. A. Winstanley, and W. M. Watkins. 1998. Kenyan Plasmodium falciparum field isolates: correlation between pyrimethamine and chlorcycloguanil activity in vitro and point mutations in the dihydrofolate reductase domain. Antimicrob. Agents Chemother. 42:164-169.
14. Peterson, D. S., W. K. Milhous, and T. E. Wellems. 1990. Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria. Proc. Natl. Acad. Sci. USA 87:3018-3022.
15. Reeder, J. C., K. H. Rieckmann, B. Genton, K. Lorry, B. Wines, and A. F. Cowman. 1996. Point mutations in the dihydrofolate reductase and dihydropteroate synthetase genes and in vitro susceptibility to pyrimethamine and cycloguanil of Plasmodium falciparum isolates from Papua New Guinea. Am. J. Trop. Med. Hyg. 55:209-213.
16. Ringwald, P., J. Bickii, and L. K. Basco. 1996. Randomised trial of pyronaridine versus chloroquine for acute uncomplicated falciparum malaria in Africa. Lancet 347:24-28.
17. Ringwald, P., J. Bickii, and L. K. Basco. 1996. In vitro activity of antimalarials against clinical isolates of Plasmodium falciparum in Yaoundé, Cameroon. Am. J. Trop. Med. Hyg. 55:254-258.
18. Sirawaraporn, W., P. Prapunwattana, R. Sirawaraporn, Y. Yuthavong, and D. V. Santi. 1993. The dihydrofolate reductase domain of Plasmodium falciparum thymidylate synthase-dihydrofolate reductase: gene synthesis, expression, and anti-folate resistant mutants. J. Biol. Chem. 268:21637-21644.
19. Sirawaraporn, W., T. Sathitkul, R. Sirawaraporn, Y. Yuthavong, and D. V. Santi. 1997. Antifolate-resistant mutants of Plasmodium falciparum dihydrofolate reductase. Proc. Natl. Acad. Sci. USA 94:1124-1129.
20. Sirawaraporn, W., S. Yongkiettrakul, R. Sirawaraporn, Y. Yuthavong, and D. V. Santi. 1997. Plasmodium falciparum: asparagine mutant at residue 108 of dihydrofolate reductase is an optimal antifolate-resistant single mutant. Exp. Parasitol. 87:245-252.
21. Smithuis, F. M., F. Monti, M. Grundl, A. Z. Oo, T. T. Kyaw, O. Phe, and N. J. White. 1997. Plasmodium falciparum: sensitivity in vivo to chloroquine, pyrimethamine/sulfadoxine and mefloquine in western Myanmar. Trans. R. Soc. Trop. Med. Hyg. 91:468-172.
22. Trigg, J. K., H. Mbwana, O. Chambo, E. Hills, W. Watkins, and C. F. Curtis. 1997. Resistance to pyrimethamine/sulfadoxine in Plasmodium falciparum in 12 villages in north east Tanzania and a test of chlorproguanil/dapsone. Acta Trop. 63:185-189.
23. Triglia, T., and A. F. Cowman. 1994. Primary structure and expression of the dihydropteroate synthetase gene of Plasmodium falciparum. Proc. Natl. Acad. Sci. USA 91:7149-7153.
24. Triglia, T., J. G. T. Menting, C. Wilson, and A. F. Cowman. 1997. Mutations in dihydropteroate synthase are responsible tor sulfone and sulfonamide resistance in Plasmodium falciparum. Proc. Natl. Acad. Sci. USA 94:13944-13949.
25. Van Dijk, M. R., A. P. Waters, and C. J. Janse. 1995. Stable transfection of malaria parasite blood stages. Science 268:1358-1362.
26. Wang, P., D. R. Brooks, P. F. G. Sims, and J. E. Hyde. 1995. A mutation-specific PCR system to detect sequence variation in the dihydropteroate synthetase gene of Plasmodium falciparum. Mol. Biochem. Parasitol. 71:115-125.
27. Wang, P., C. S. Lee, R. Bayoumi, A. Djimde, O. Doumbo, G. Swedberg, L. D. Dao, H. Mshinda, M. Tanner, W. M. Watkins, P. F. G. Sims, and J. E. Hyde. 1997. Resistance to antifolates in Plasmodium falciparum monitored by sequence analysis of dihydropteroate synthetase and dihydrofolate reductase alleles in a large number of field samples of diverse origins. Mol. Biochem. Parasitol. 89:161-177.
28. Wang, P., M. Read, P. F. G. Sims, and J. E. Hyde. 1997. Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization. Mol. Microbiol. 23:979-986.
29. Warrell, D. A., M. E. Molyneux, and P. F. Beales. 1990. Severe and complicated malaria. Trans. R. Soc. Trop. Med. Hyg. 84(Suppl. 2):1-65.
30. Wernsdorfer, W. H. 1994. Epidemiology of drug resistance in malaria. Acta Trop. 56:143-156.
31. Wernsdorfer, W. H., and D. Payne. 1991. The dynamics of drug resistance in Plasmodium falciparum. Pharmacol. Ther. 50:95-121.
32. World Health Organization. 1990. Practical chemotherapy of malaria. WHO Tech. Rep. Ser. 805:1-160.
33. World Health Organization Division of Control of Tropical Diseases. 1996. Assessment of therapeutic efficacy of antimalarial drugs for uncomplicated falciparum malaria in areas with intense transmission. WHO/MAL/96.1077. World Health Organization, Geneva, Switzerland.
34. Wu, Y., L. A. Kirkman, and T. E. Wellems. 1996. Transformation of Plasmodium falciparum malaria parasites by homologous integration of plasmids that confer resistance to pyrimethamine. Proc. Natl. Acad. Sci. USA 93: 1130-1134.
35. Zindrou, S., P. D. Nguyen, D. S. Nguyen, O. Sköld, and G. Swedberg. 1996. Plasmodium falciparum: mutation pattern in the dihydrofolate reductase-thymidylate synthase genes of Vietnamese isolates, a novel mutation and coexistence of two clones in a Thai patient. Exp. Parasitol. 84:56-64.